Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Patient Education Materials for Non-English Speakers

Katie Robinson  |  Issue: July 2023  |  July 10, 2023

The Lupus Foundation of America has videos on its website and posts videos on its social media channels. “Our YouTube channel has about 350 videos covering a wide range of topics related to lupus. Last year we posted approximately 50 videos to Instagram that were either created by Lupus Foundation of America staff or by trusted partners,” Ms. French says.

Johns Hopkins Medicine’s Rheum.TV is another information platform created to educate patients who are living with a rheumatic disease. Although available only in English, Rheum.TV includes more 140 videos on a wide range of diseases, including exercise, medication and lifestyle tips. “Our videos have had more than 11 million views,” says Victoria Ruffing, RN, BC-Rheumatology, director of nursing and patient education at the Johns Hopkins Arthritis Center, Baltimore. “They are available through Rheum.TV, YouTube and Facebook,” she says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Scope of Need

According to Dr. Ursani, there is a significant need for patient education and outreach content. “Although awareness of rheumatic and autoimmune diseases is increasing, there is a significant need to continue to educate the public, healthcare providers and policymakers to help improve outcomes for our patients,” he says.

The materials from the ACR have proved beneficial for providers and their patients.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Last year, the diseases and treatments patient fact sheets ranked as the second-most sought-after pages on the ACR website, receiving nearly 3 million views. Additionally, month after month, the patient-focused newsletter has an open rate of 33.5%, which exceeds the industry standard, and the patient-focused social media audience and engagement rate increased,” Dr. Ursani says.

Dr. Sattui explains that “being diagnosed with any chronic condition is challenging, but the challenges are even greater when the disease is rare and knowledge and awareness of the condition are limited. Most resources have been developed in the U.S. and Europe, where the majority of research takes place and where the largest patient organizations exist. Providing patients access to information is crucial, and this should be available to all patients independent of their native language.

“Knowledge empowers patients to be more active in their care as they work with their medical team to achieve good outcomes. It also allows patients to educate their family and friends, provide more visibility to these rare diseases and create awareness. This is particularly important for rare diseases such as vasculitis,” Dr. Sattui adds.

For people with lupus, the need for accurate, easy-to-understand health and medical information is particularly acute. “Lupus is a complex illness and people who have it often have the additional challenge of fatigue and brain fog, which can complicate their ability to understand the disease and participate in treatment decisions and disease self-management. This is compounded when people are not comfortable communicating in English,” Ms. French says.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Patient PerspectivePractice Management Tagged with:health literacypatient education

Related Articles
    Hanna Kuprevich / shutterstock.com

    How to Help Your Patients Find Credible Information about Their Disease

    May 17, 2019

    Where can patients obtain more information about their diagnoses and prescription drugs, and answers to the assortment of questions they have about living with a chronic disease once they leave the rheumatologist office? Patient education materials can be found in many places on the internet, but those looking for answers may need a helping hand…

    Fall 2021’s Awards, Appointments & Announcements in Rheumatology

    October 13, 2021

    Jeffrey Siegel, MD, Assumes New Position as Director for New Office of Drug Evaluation Sciences at the FDA On Feb. 16, Jeffrey Siegel, MD, became the director of the recently created Office of Drug Evaluation Sciences at the U.S. Food & Drug Administration (FDA). The move, he says, “puts together many of the different things…

    How Rheumatologists Can Boost Patient Understanding of Educational Materials

    April 2, 2014

    Choosing appropriate, pre-written disease fact sheets, or writing your own educational documents can help patients with low health literacy comprehend information about their condition

    ilusmedical / shutterstock.com

    The State of Clinical Research in Vasculitis: 2021

    January 19, 2021

    It is an exciting time in the world of vasculitis research. More clinical studies and trials are being conducted now than at any time in history. In the past ten years, four drugs have been approved by the U.S. Food & Drug Administration (FDA) and other regulatory agencies specifically for the treatment of vasculitis: Rituximab…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences